(경영학원론 A+) 유한양행 기업분석 보고서

소개

대학교 경영학원론 수업에서 A+을 받았던 유한양행 기업분석 보고서입니다.

목차

1.Introduction

2.Company overview

3.Industry Analysis
1)Internal Analysis: Competitive Advantage
2)External Analysis: 5 Forces Model

4.Corporate Governance and Ethics
1)Shareholder Structure
2)Corporate Social Responsibility (CSR)

5.Organizational Strategy
1)Organizational Culture
2)HR & Marketing Strategy

6.Conclusion

본문내용

Introduction
When watching the news, there are often cases where the immoral behavior of a company CEO becomes controversial, with incentive headlines such as “A Company’s CEO arrested for embezzlement case” or “B Company’s collusion between politics and business”. Such examples include so-called “갑질” cases where vast corporate funds are used for personal gain or employees are treated unfairly. In this case, the company's image becomes negative, and it may even lead to a consumer boycott. In this way, a company's image has a negative impact on its sales and performance.
On the contrary, there may be cases where a good corporate image has a positive effect on corporate management. Since most news covers cases where a company's image has suffered due to a negative event, there was no example that immediately came to mind in this case. Then I remembered the professor talking about “Yuhan Corporation,” a representative company with a positive image. I thought it would be interesting to analyze in depth how Yuhan Corporation's positive corporate image was created and what impact this image had on corporate management.
What competitive advantages does Yuhan Corporation have in the pharmaceutical industry? How will Yuhan Corporation’s CSR and organizational structure affect corporate management? I would like to discuss Yuhan Corporation's footsteps and its future vision on topics such as these. Lastly, I would like to find out what relationship Yuhan Corporation's ethical management and good image have with the company's survival.

Company Overview
Yuhan Corporation is Korea's first pharmaceutical company, founded in 1926 by Dr. Yu Ilhan. The company was founded to improve the health and welfare of the country's citizens at a time when the country was suffering from disease and hygiene problems. This motto continues to these days, and Yuhan Corporation focuses on pharmaceutical research and development and produces medicines such as painkillers, anticancer drugs, and antibiotics.

참고자료

· Lee, MJ. (2023, June 9). "유한양행, '연매출액 2조' 전인미답 눈앞...'주인없는 제약사' 성공비결은." 더밸류뉴스. https://www.thevaluenews.co.kr/news/view.php?idx=175993
· Park, IW. (2018, June 25). "[살맛나는세상이야기]유한양행 - '국내 최초' 기업의 사회적 책임 모델." metro. https://www.metroseoul.co.kr/article/*************
· Kim, JS. (2024, June 7). "유한양행 '렉라자' 데이터 중무장...예상 점유율 40%, 판매 로열티는?." PHARM EDAILY. https://pharm.edaily.co.kr/news/read?newsId=01708886638919424&mediaCodeNo=257
· Ingrid Torjesen. (2015, May 12). “Drug development: the journey of a medicine from lab to shelf.” the PHARMACEUTICAL JOURNAL. https://pharmaceutical-journal.com/article/feature/drug-development-the-journey-of-a-medicine-from-lab-to-shelf
· Yuhan Corporation, https://www.yuhan.co.kr/Research/Vision/
· Lee, MJ. (2023, June 9). "유한양행, '연매출액 2조' 전인미답 눈앞...'주인없는 제약사' 성공비결은." 더밸류뉴스. https://www.thevaluenews.co.kr/news/view.php?idx=175993
· Noh, YH. (2024, March 22). "2023년 주요 제약사 3곳 中 2곳, 연구개발비 투자 늘렸다." medifonews. https://www.medifonews.com/mobile/article.html?no=189122